Finance

Lists
Why is TNYA down 6,78%?
Dive Deeper
TNYA:NASDAQ
Tenaya Therapeutics Inc
0,38 $
-6,78%
(-0,028) 1D
0,38 $
+1,13% (+0,0043)
After hours
Closed: 16 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNYA...
Open
0,41 $
High
0,42 $
Low
0,37 $
Mkt. cap
85,53 մլն
Avg. vol.
3,42 մլն
Volume
6,84 մլն
52-wk high
2,02 $
52-wk low
0,36 $
EPS
-0,53 $
Beta
2,87
Shares outstanding
224,23 մլն
No. of employees
70
Open
0,41 $
High
0,42 $
Low
0,37 $
Mkt. cap
85,53 մլն
Avg. vol.
3,42 մլն
Volume
6,84 մլն
52-wk high
2,02 $
52-wk low
0,36 $
EPS
-0,53 $
Beta
2,87
Shares outstanding
224,23 մլն
No. of employees
70
News stories
From web sources and news partners
About Tenaya Therapeutics Inc
CEO-
Employees70
Founded2016
HeadquartersSouth San Francisco, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to TNYA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TNYA in the last 3 months.
Highest
Current 0,38 $
40,00 $ (+10 406,96%)
Average
13,00 $ (+3 314,76%)
Lowest
3,00 $ (+688,02%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
3,00 $
+688%
10/05/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
5,00 $
+1 213,4%
08/06/2026
Cory Jubinville, PhD
LifeSci Capital
Buy
Maintained
4,00 $
+950,7%
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
40,00 $
+10 407%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
07/29/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
2,00 $
+425,3%
06/03/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
8,00 $
+2 001,4%
05/15/2026
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,09 $ / -0,07 $
-35,90%miss
Revenue / Est. (USD)
1,11 մլն / 10,00 մլն
-88,90%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
225,00 հզր
1,11 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,36 մլն
14,80 մլն
14,84 մլն
16,60 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,57 մլն
5,98 մլն
5,45 մլն
5,41 մլն
Operating expense
20,94 մլն
20,78 մլն
20,29 մլն
22,01 մլն
Total operating expenses
20,94 մլն
20,78 մլն
20,29 մլն
22,01 մլն
Operating income
-20,94 մլն
-20,78 մլն
-20,06 մլն
-20,90 մլն
Other non operating income
3,00 հզր
25,00 հզր
-
-1,37 մլն
EBT including unusual items
-20,28 մլն
-20,18 մլն
-19,27 մլն
-43,39 մլն
EBT excluding unusual items
-20,28 մլն
-20,18 մլն
-19,27 մլն
-21,57 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20,28 մլն
-20,18 մլն
-19,27 մլն
-43,39 մլն
Net profit margin
-
-
-8 565,33%
-3 909,28%
Earnings per share
-0,12
-0,12
-0,09
-0,09
Interest and investment income
658,00 հզր
575,00 հզր
793,00 հզր
697,00 հզր
Interest expense
-
-
-
-
Net interest expenses
658,00 հզր
575,00 հզր
793,00 հզր
697,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,07 մլն
-18,95 մլն
-18,30 մլն
-19,20 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps